NCT06300151 The Effect of Ultrasound Real-time Guidance Technique on the Effectiveness and Safety of Labor Analgesia
| NCT ID | NCT06300151 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zongxun Lin |
| Condition | Labor Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2024-04-01 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ultrasound real-time guidance technology has great advantages over traditional blind exploration technology in terms of accuracy, success rate, and reduction of puncture damage in intervertebral space positioning through operational visualization, greatly improving the effectiveness and safety of spinal block. At present, Doppler ultrasound is rarely used for spinal block, especially for real-time ultrasound guidance technology, which has not been widely applied in clinical practice due to its high equipment requirements, lack of mature puncture plans, complex operation, and high learning curve. If a comprehensive diagnosis and treatment plan can be developed, it will greatly improve the delivery experience of mothers.
Eligibility Criteria
Inclusion Criteria: 1. American Society of Anesthesiologists (ASA) Class I or II; 2. Single healthy pregnancy; 3. Head showing first; 4. 37 to 41 weeks; 5. The labor process is active, and the cervix dilates\<5cm; 6. Require epidural labor analgesia; 7. Volunteer to participate in this study and sign an informed consent form. Exclusion Criteria: 1. Presence of pregnancy diseases, such as pregnancy hypertension, pre eclampsia, pregnancy diabetes; 2. Contraindications to intraspinal analgesia: 1) Central nervous system diseases. 2) Infection or septicemia at the puncture site. 3) Coagulation dysfunction; 3. Known cases of fetal malformation or increased risk of cesarean section, such as a history of uterine rupture; 4. Persons with a history of mental illness, hysteria, epilepsy, etc. who cannot cooperate. 5. Patients with long-term use of opioids, steroids, and chronic pain.
Contact & Investigator
Zongxun Lin, Master
PRINCIPAL INVESTIGATOR
Fujian Provincial Hospital
Frequently Asked Questions
Who can join the NCT06300151 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Labor Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06300151 currently recruiting?
Yes, NCT06300151 is actively recruiting participants. Contact the research team at 13763820916@189.cn for enrollment information.
Where is the NCT06300151 trial being conducted?
This trial is being conducted at Fuzhou, China.
Who is sponsoring the NCT06300151 clinical trial?
NCT06300151 is sponsored by Zongxun Lin. The principal investigator is Zongxun Lin, Master at Fujian Provincial Hospital. The trial plans to enroll 80 participants.